NCT03037762

Brief Summary

Neurogenic dysphagia is one of the most frequent and prognostically relevant neurological deficits in a variety of disorders, such as stroke, parkinsonism and advanced neuromuscular diseases. Flexible endoscopic evaluation of swallowing (FEES) is now probably the most frequently used tool for objective dysphagia assessment in Germany. It allows evaluation of the efficacy and safety of swallowing, determination of appropriate feeding strategies and assessment of the efficacy of different swallowing manoeuvres. The literature furthermore indicates that FEES is a safe and well-tolerated procedure. The FEES-Registry aims at evaluating findings and side effects of FEES in a heterogeneous collective of patients with neurogenic dysphagia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,401

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

January 12, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 31, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

November 29, 2019

Status Verified

November 1, 2019

Enrollment Period

2.8 years

First QC Date

January 12, 2017

Last Update Submit

November 27, 2019

Conditions

Outcome Measures

Primary Outcomes (7)

  • FEES-related side effects - 1. systolic blood pressure increase

    Systolic blood pressure will be measured directly prior, during and after the procedure. The initial value will be compared to the highest blood pressure value measured during/directly after the procedure.

    during the procedure

  • FEES-related side effects - 2. Oxygen saturation decline

    Oxygen saturation will be measured directly prior, during and directly after the procedure. The initial value will be compared to the lowest value measured during/directly after the procedure.

    during the procedure

  • FEES-related side effects - 3. Heart rate decrease

    Heart rate will be measured directly prior, during and directly after the procedure. The initial value will be compared to the lowest value measured during/directly after the procedure.

    during the procedure

  • FEES-related side effects - 4. Nose bleed

    Number of patients with nose bleed during the procedure

    during the procedure

  • FEES-related side effects - 5. Laryngospasm

    Number of patients with laryngospasm during the procedure

    during the procedure

  • FEES-related side effects - 6. Decreased level of consciousness

    Number of patients with a decline in consciousness during the procedure (measured with the Richmond agitation and sedation scale)

    during the procedure

  • Patients subjective FEES-related discomfort

    Number of patients with procedure related discomfort measured with a 4 point scale ranging from 1=no discomfort to 4=extremely painful sensation during the procedure

    during the procedure

Secondary Outcomes (1)

  • Changes of dietary status after FEES

    immediately prior and immediately after the procedure

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with suspected neurogenic dysphagia

You may qualify if:

  • suspected neurogenic dysphagia
  • Patients being scheduled for a FEES
  • written informed consent

You may not qualify if:

  • \- none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Münster, 48149, Germany

Location

Related Publications (1)

  • Dziewas R, Auf dem Brinke M, Birkmann U, Brauer G, Busch K, Cerra F, Damm-Lunau R, Dunkel J, Fellgiebel A, Garms E, Glahn J, Hagen S, Held S, Helfer C, Hiller M, Horn-Schenk C, Kley C, Lange N, Lapa S, Ledl C, Lindner-Pfleghar B, Mertl-Rotzer M, Muller M, Neugebauer H, Ozsucu D, Ohms M, Perniss M, Pfeilschifter W, Plass T, Roth C, Roukens R, Schmidt-Wilcke T, Schumann B, Schwarze J, Schweikert K, Stege H, Theuerkauf D, Thomas RS, Vahle U, Voigt N, Weber H, Werner CJ, Wirth R, Wittich I, Woldag H, Warnecke T. Safety and clinical impact of FEES - results of the FEES-registry. Neurol Res Pract. 2019 Apr 26;1:16. doi: 10.1186/s42466-019-0021-5. eCollection 2019.

Study Officials

  • Rainer Dziewas, MD

    University Hospital Muenster, Department of Neurology, Germany

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2017

First Posted

January 31, 2017

Study Start

October 1, 2014

Primary Completion

August 1, 2017

Study Completion

October 1, 2017

Last Updated

November 29, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations